Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 19, 2004. The report details changes in directors' interests in the company's Ordinary Shares, specifically regarding transactions involving the GlaxoSmithKline Employee Trust (GSK Trust).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transactions and does not contain financial performance data.
Material Changes
The filing reports specific share movements on November 17 and 18, 2004, involving the GSK Trust:
- November 17, 2004: Transfer of 20,282 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- November 18, 2004: Transfer of 4,459 Ordinary Shares to a participant in the SmithKline Beecham Mid Term Incentive Plan.
- November 18, 2004: Sale of 3,099 Ordinary Shares on behalf of a participant in the SmithKline Beecham Mid Term Incentive Plan at a price of £11.9015 per share.
- November 18, 2004: Transfer of 3,358 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. It notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe) hold interests in the GSK Trust in the same capacity as other employees or former employees.
Key Facts for Investor Verification
- Verify the total number of shares transferred or sold from the GSK Trust during the reporting period (Total: 31,198 shares involved in transfers/sales).
- Confirm the transaction price of £11.9015 per share for the sale on November 18, 2004.
- Review the specific plans involved: SmithKline Beecham Employee Share Option Plan 1991 and SmithKline Beecham Mid Term Incentive Plan.
- Note that the filing contains no financial performance data; investors should refer to Form 20-F for comprehensive financial results.